Complications and difficulties in radiolabelling blood cells: A review

Nuclear Medicine Communications

Volumn 17, Issue 8, 1996, Pages 648-658

  Sampson, C B ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; AZATHIOPRINE; BETAHISTINE; CIPROFLOXACIN; CODEINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIAZEPAM; DOXORUBICIN; FOLIC ACID; HEPARIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HYDROCORTISONE; METRONIDAZOLE; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYTOIN; PREDNISOLONE; RANITIDINE; SPIRONOLACTONE; TEMAZEPAM; TETRACYCLINE; UNINDEXED DRUG;

BLOOD CELL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISOTOPE LABELING; REVIEW;

EID: 0029739988     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199608000-00002     Document Type: Article

References (66)

1. Thakur ML. Indium-111 labelled leucocytes for the localisation of abcesses: Preparation, analysis, tissue distribution and comparison with gallium-67 citrate in dogs. Lab Clin Med 1977; 89: 217-228.
2. Fischer J, Wolf R, Leon A. Technetium-99m as a label for erythrocytes. J Nucl Med 1967; 8: 229.
3. Sewchand LS, Canham PB. Modes of rouleaux formation of human red blood cells in polyvinylpyrrolidone and dex- tran solutions. Can J Physiol 1979; 57: 1213-1223.
4. Sampson CB, Solanki C. Separation and technetium labelling of pure neutrophils: Development of a simple and rapid protocol. Nucl Med Cotntnun 1992; 13: 210.
5. Danpure HJ. Radiolabelling of blood cells. In: Sampson CB, ed. Textbook of radiopharmacy: Theory and practice. London: Harwood Academic, 1994: 75-86.
6. Glasstone S. Stokes's Law. In: Glasstone S, ed. Textbook of physical chemistry. London: Macmillan, 1940: 489.
7. Boyum A. Separation of white blood cells. Nature 1964; 204: 793-801.
8. Dormandy JA. Clinical significance of blood viscosity Ann R Coll Surg Engl 1970; 47: 211-228.
9. Hutchinson RM, Eastham RD. A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins. J Clin Pathol 1977; 30: 345-349.
10. Sampson CB, Solanki C. Does plasma fat, viscosity, or erythrocyte sedimentation rate affect the radiolabelling of leucocytes? Nucl Med Commun 1989; 10: 224.
11. Sampson CB. Interference of patient medication in the radiolabelling of blood cells: in-vitro and in-vivo effects. In: Sinzinger H, ed. Radioactive isotopes in clinical medicine and research. Basel: Birkhauser, 1995: 315-322.
12. Bunting H. Sedimentation rates of sickled and non-sickled cells from patients with sickle cell anaemia. Am J Med Sci 1940; 198: 191-193.
13. Winser T, Burch G. Diagnostic physicochemical blood tests in sickle cell anaemia. Am Med Sci 1944; 207: 152-155.
14. In: Bell G, Emslie-Smith D, Paterson C, eds. Textbook of physiology, 10th edn. London: Churchill Livingstone, 1985: 11.
15. Package insert for Accuspin System. Sigma Diagnostics, USA, Germany, UK, 1992.
16. Merz T. Technetium-99m labelled lymphocytes: A radiotoxicity study. J Nucl Med 1986; 27: 105-110.
17. Peters M. Recent advances in cell labelling (editorial). Nucl Med Commun 1987; 8: 313-316.
18. Danpure H. Specifications and quality control methods for labelled cells. In: Kristensen K, Norbygaard E, eds. Safety and efficacy of radiopharmaceuticals. Dordrecht: Martinus Nijhoff, 1987: 161-184.
19. ten Berge RY, Natarajan AT. Labelling with indium-111 has detrimental effects on human lymphocytes: Concise communication. J Nucl Med 1983; 24: 615-619.
20. Sampson CB. Technetium labelled lymphocytes: A plain man's guide to separation and radiolabelling. Nucl Med Commun 1992; 13: 400.
21. Sampson CB, Solanki C. Tc-99m exametazime labelled leucocytes:A high-efficiency multi-dose radiolabellingmethod using a high concentration and low volume of ligand. Nucl Med Commun 1992; 12: 719-723.
22. Ceretec package insert. Amersham International pic, Amersham Place, Little Chalfont, Bucks HP7 9NA, UK.
23. Solanki K. A rapid method for the Tc-99m hexametazime labelling of leucocytes. Nucl Med Commun 1988; 9: 753-761.
24. Danpure H. Cell labelling with In-111 complexes. In: Theobald AE, ed. Radiopharmacy and radiopharmaceuticals. London: Taylor and Francis, 1985: 51-85.
25. Roddie ME. Imaging inflammation with Tc-99m hexamethyl propylene amine oxime (HMPAO) labelled leucocytes. Radiology 1988; 166: 767-772.
26. Neirinckx RD, Canning LR, Piper IM et al. The retention mechanism of technetium-99m labelled HMPAO: Intracellular reaction with glutathione. J Cereb Blood Flow Metab 1988; 8: S4-S12.
27. Nowotnik D. Physico-chemical concepts of technetium radiopharmaceuticals. In: Sampson CB, ed. Textbook of radiopharmacy: Theory and practice. London: Harwood Academic, 1994: 29-49.
28. Sampson CB. Stabilisation of Tc-99m exametazime using ethanol and storage at a low temperature. In Proceedings of the European Association of Nuclear Medicine Congress, Vienna, 1991 (Abstract No. FP-212-4).
29. Ballinger J. Preparation of Tc-99m HMPAO. J Nucl Med 1990; 31: 26-31.
30. Solanki C, Wong A, Sampson CB, et al. Stabilisation of exametazime for leucocyte labelling: A new approach using tin enhancement. Nucl Med Commun 1993; 13: 1035-1040.
31. Mountford PJ, Allsopp MJ, Baird AC et al. A study of leucocyte labelling efficiency obtained with In-111 oxine. Nucl Med Commun 1985; 6: 109-114.
32. In: Aronson JK, van Boxted CJ eds. Myler’s side effects of drugs annual 17. Amsterdam: Elsevier, 1993: 1293-1294.
33. Macgregor RR, Spaguolo PJ, Lentner AL. Inhibition of granulocyte adherence by ethanol, prednisone and aspirin measured with an assay system. New Engl J Med 1974; 56: 642-645.
34. Macgregor RR, Thomer RE, Wright DNM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 1980; 2: 203-207.
35. Nielsen VG, Webster RO. Inhibition of polymorphonuclear leukocyte functions by ibuprofen. Immunopharmacol 1987; 13: 61-71.
36. Cairo MS, Mallett C, Van de Ven C et al. Impaired in-vitro polymorphonuclear function secondary to the chemotherapeutic effects of vincristine, adriamycin, cyclophosphamide and actinomycin-D. J Clin Oncol 1986; 4: 798-804.
37. Abramson SB, Weissman G. The mechanism of action of non-steroidal anti-inflammatory drugs. Arthritis and Rheumatism 1989; 32: 1-9.
38. In: Reynolds JEF, ed. Martindale - The extra pharmacopoeia. London: Pharmaceutical Press, 1993: 457-458.
39. In: Reynolds JEF, ed. Martindale - The extra pharmacopoeia. London: Pharmaceutical Press, 1993: 515-521.
40. In: Reynolds JEF, ed. Martindale - The extra pharmacopoeia. London: Pharmaceutical Press, 1993: 875.
41. Vlodavsky I, Cohen I. Anti-inflammatory effects of heparin and its derivatives: Inhibition of complement and of lymphocyte migration. Adv Exp Med Biol 1992; 313: 329-340.
42. Sampson CB. Effect of patient medication on white cell labelling. Br J Radiol (in press).
43. Weinstein MB, Smoak WM. Technical difficulties in the Tc- 99m labelling of erythrocytes. J Nucl Med 1970; 11: 41-46.
44. Eckelman W, Richards P, Hauser W et al. Technetium labelled red blood cells. J Nucl Med 1971; 12: 22-26.
45. Atkins HL, Eckelman W, Klopper JF, et al. Vascular imaging with Tc-99m red blood cells. Radiology 1973; 106: 357-363.
46. Sristava SC, Chervu LR. Radionuclide-labeled red blood cells: Current status and future prospects. Sem Nucl Med 1984; 14: 68-82.
47. Callahan RI, Froelich JW, McKusick KA et al. A modified method for the in vivo labelling of red blood cells with Tc-99m: Concise communication. J Nucl Med 1982; 23: 315-317.
48. Morse EE. Toxic effects of drugs on erythrocytes. Ann Clin Lab Sci 1988; 18: 13-18.
49. Ammus S, Yunis AA. Drug induced red cell dyscrasias. Blood Rev 1989; 3: 71-82.
50. Zimmer AM, Spies M, Majewski W. Effects of drugs on in- vivo RBC labelling: A proposed mechanism of inhibition. In Proceedings of the Second International Symposium of Radiopharmacy, Chicago, IL, 1981.
51. Lee HB, Wexler JP. Pharmacologic alterations in Tc-99m binding by red blood cells: Concise communication. J Nucl Med 1983; 24: 894-897.
52. Zanelli GD. Effect of certain drugs used in the treatment of cardiovascular disease on the in-vitro labelling of red blood cells with Tc-99m. Nucl Med Commun 1982; 3: 155-161.
53. Allen ML, McPherson AL, Mertes BJ et al. Effects of cyclosporine in lowering red blood cell technetium-99m labellingefficiency. J Nucl Med Technol 1990; 18: 191-193.
54. Gleue AD, Spicer JA, Preston DF. The effect of cyclosporine on technetium-99m red blood cell labeling using the Ultratag RBC in-vitro kit. J Nucl Med Technol 1995; 23: 22-25.
55. Blake GL. Modification by nifedipine of 1-131 meta-iodo- benzylguanidine kinetics in malignant phaeochromocy- toma. Eur J Nucl Med 1988; 14: 345-348.
56. Gutfilen B, Boasquevisque EM, Bemardo-Filho M. Calcium channel blockers: Interference on red blood cell and plasma protein labeling with Tc-99m. Rev Esp Med Nucl 1992; 11: 195-199.
57. Gutfilen B, Boasquevisque EM, Bemardo-Filho M. The effect of gentamicin, nifedipine, and verapamil on the labelling of red blood cells and plasma proteins with Tc- 99m. In Proceedings of the 6th International Symposium on Radiopharmacology, Sydney, 1989: 19.
58. Wijnands MJ, Nuver-Zwart H, van Riel, et al. Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients. ScanJ Rheumatol 1991; 20: 52-57.
59. van Hees PA, van Elferen LW, van Rossum JM. Hemolysis during salicylazosulfapyridine therapy. Am J Gastroenterol 1978; 70: 501-505.
60. In: Aronson JK, van Boxted eds. Myler’s side effects of drugs annual 17. Amsterdam: Elsevier, 1993: 1294-1295.
61. Tatum JL, Burke TS, Hirsch JI et al. Decreased red cell tagging in patients who had received iodinated contrast media. Clin Nucl Med 1983; 18: 585-586.
62. Porter WC, Dees SM, Freitag JE. Effect of heparin and acid- citrate-dextrose on labelling efficiency of Tc-99m labelled RBCs. J Nucl Med 1983; 24: 383-385.
63. Mazzole AC, Barker MM, Belliveal RE. Accumulation of Tc-99m diphosphonate at sites of intramuscular iron therapy. J Nucl Med Technol 1976; 4: 133-135.
64. Hegge FN, Hamilton GW, Larson SM. Cardiac chamber imaging: A comparison of red blood cells labelled with Tc- 99m in-vitro and in-vivo. J Nucl Med 1978; 19: 129-134.
65. Millar AMN, Wathen CJ, Muir AL. Failure in labelling of red cells with Tc-99m: Interactions between intravenous cannulae and stannous pyrophosphate. Eur J Nucl Med 1989; 8: 502-504.
66. Frier M. Effect of injection technique on the stability of radiopharmaceuticals. Nucl Med Commun 1992; 13: 230.